226 related articles for article (PubMed ID: 17979756)
1. Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals.
Cvek B; Dvorak Z
Curr Pharm Des; 2007; 13(30):3155-67. PubMed ID: 17979756
[TBL] [Abstract][Full Text] [Related]
2. Biphasic effects of dithiocarbamates on the activity of nuclear factor-kappaB.
Kim CH; Kim JH; Moon SJ; Hsu CY; Seo JT; Ahn YS
Eur J Pharmacol; 2000 Mar; 392(3):133-6. PubMed ID: 10762665
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
[TBL] [Abstract][Full Text] [Related]
5. Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells.
Yu H; Lou JR; Ding WQ
Anticancer Res; 2010 Jun; 30(6):2087-92. PubMed ID: 20651355
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram.
Lövborg H; Oberg F; Rickardson L; Gullbo J; Nygren P; Larsson R
Int J Cancer; 2006 Mar; 118(6):1577-80. PubMed ID: 16206267
[TBL] [Abstract][Full Text] [Related]
7. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
[TBL] [Abstract][Full Text] [Related]
8. [Effect of ubiquitin-proteasome pathway on inflammatory reaction in intestine and its barrier function in rats with postburn sepsis].
Yin HN; Chai JK; Yao YM; Shen CA; Wu YQ; Ma ZF; Liu Q; Sheng ZY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):649-52. PubMed ID: 17092411
[TBL] [Abstract][Full Text] [Related]
9. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
10. Uraemic serum induces dysfunction of vascular endothelial cells: role of ubiquitin-proteasome pathway.
Feng B; Zhang YQ; Mu J; Yuan FH; Ye ZL; Qi W; Guo YH; Zeng W; Luo ZF
Exp Physiol; 2011 Aug; 96(8):801-15. PubMed ID: 21602294
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of NF-kappaB activation pathways and the induction of apoptosis by dithiocarbamates in T cells are blocked by the glutathione precursor N-acetyl-L-cysteine.
Fernandez PC; Machado J; Heussler VT; Botteron C; Palmer GH; Dobbelaere DA
Biol Chem; 1999 Dec; 380(12):1383-94. PubMed ID: 10661865
[TBL] [Abstract][Full Text] [Related]
12. Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-kappaB activation.
Kim CH; Kim JH; Hsu CY; Ahn YS
FEBS Lett; 1999 Apr; 449(1):28-32. PubMed ID: 10225421
[TBL] [Abstract][Full Text] [Related]
13. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.
Grover A; Shandilya A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S15. PubMed ID: 21143798
[TBL] [Abstract][Full Text] [Related]
14. Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death.
Schumacher M; Cerella C; Eifes S; Chateauvieux S; Morceau F; Jaspars M; Dicato M; Diederich M
Biochem Pharmacol; 2010 Feb; 79(4):610-22. PubMed ID: 19814997
[TBL] [Abstract][Full Text] [Related]
15. Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.
Buac D; Schmitt S; Ventro G; Kona FR; Dou QP
Mini Rev Med Chem; 2012 Oct; 12(12):1193-201. PubMed ID: 22931591
[TBL] [Abstract][Full Text] [Related]
16. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
[TBL] [Abstract][Full Text] [Related]
17. Targeting the NF-κB pathway in cancer therapy.
Erstad DJ; Cusack JC
Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
[TBL] [Abstract][Full Text] [Related]
18. Fetal bovine serum requirement for pyrrolidine dithiocarbamate-induced apoptotic cell death of MCF-7 breast tumor cells.
Oh DH; Bang JS; Choi HM; Yang HI; Yoo MC; Kim KS
Eur J Pharmacol; 2010 Dec; 649(1-3):135-9. PubMed ID: 20868670
[TBL] [Abstract][Full Text] [Related]
19. The nuclear factor-kappa B pathway regulates cytochrome P450 3A4 protein stability.
Zangar RC; Bollinger N; Verma S; Karin NJ; Lu Y
Mol Pharmacol; 2008 Jun; 73(6):1652-8. PubMed ID: 18334598
[TBL] [Abstract][Full Text] [Related]
20. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
